Lipid profiles of Thai adult HIV-infected patients receiving protease inhibitors.

Dyslipidemia is a common metabolic complication among HIV-infected patients who receive protease inhibitor (PI)-based antiretroviral therapy (ART). In order to assess the prevalence of lipid abnormalities and related factors, a cross-sectional analytic study of the lipid profiles of 170 Thai adult HIV-infected patients receiving PI-containing HAART who attended the HIV-clinic, King Chulalongkorn Memorial Hospital, Bangkok, Thailand between January and August 2005 was conducted. Studied subjects had a median age of 40 years with a median duration of taking PIs of 22.

Physician adherence to isoniazid preventive therapy guidelines for HIV-infected patients in Thailand.

Isoniazid preventive therapy (IPT) has been shown to reduce the risk of active tuberculosis in tuberculin skin test (TST) positive human immunodeficiency virus (HIV) infected individuals. The World Health Organization has recommended IPT for HIV-infected patients since 1999. Physicians' non-adherence to the IPT guideline is one of the limitations to the wide spread use of IPT.